Hypercoagulable State Associated with COVID-19 Infection



About this Webinar

Date: Thursday, November 12, 2020

Author: Racke, Frederick K., MD, PhD.
Medical Director, Hematology/Oncology and Coagulation,
Nichols Institute
Quest Diagnostics
San Juan Capistrano, CA
Also by this Author 

Author: Wong, Edward C. C., MD
Medical Director, Quest Diagnostics; Adj Assoc Professor, George Washington School of Medicine and Health Sciences; Clinical Consultant, Children’s National Hospital  
Also by this Author 

Category: Webinar

Description: • Identify key coagulation markers that are associated with increased mortality in COVID-19 infected patients
• Distinguish COVID-19 hypercoagulability from other hypercoagulable states
• Understand key laboratory issues associated with thrombophilia testing and anticoagulant monitoring in patients with COVID-19 infection